Literature DB >> 8257288

The pathogenicity of a US3 protein kinase-deficient mutant of herpes simplex virus type 2 in mice.

R Kurachi1, T Daikoku, T Tsurumi, K Maeno, Y Nishiyama, T Kurata.   

Abstract

We have investigated the pathogenicity of a US3 protein kinase-deficient mutant (L1 BR1) of herpes simplex virus type 2 (HSV-2) for 4-week-old ICR mice to define the role of the viral protein kinase in virus-host interaction. When mice were intraperitoneally infected with 10(5)PFU of L1 BR1, the virus disappeared from the peritoneal cavity by 2 days postinfection and failed to induce any significant histopathological changes in the liver and spleen although viral antigens were occasionally detected in the epithelial cells of small bile ducts and small vascular wall. The parental virus (HSV-2 186) and a revertant of the mutant (L1 B-11) both caused severe hepatitis, and viral antigens were clearly detected in the hepatocytes and Kupffer cells in the focal necrotic areas. Both of the virulent viruses, unlike L1 BR1, could produce infectious progeny and cytopathic effects in freshly harvested peritoneal macrophages. The growth of L1 BR1 in peritoneal macrophages was restricted at a stage of or prior to viral DNA synthesis but after the induction of viral DNA polymerase. In addition, the production and/or the spread of mutant in mouse embryo fibroblasts (MEF) was found to be much more effectively suppressed by cocultivation of peritoneal macrophages than that of 186. An almost complete inhibition of L1 BR1-plaque formation was observed at a macrophage-to-MEF ratio of 4:1. These results suggest that the attenuation of L1 BR1 following intraperitoneal infection is primarily due to its high sensitivity to intrinsic and extrinsic inhibition of peritoneal macrophages and that the US3 protein kinase may play a role in viral DNA replication in peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257288     DOI: 10.1007/bf01313767

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  Construction of a US3 lacZ insertion mutant of herpes simplex virus type 2 and characterization of its phenotype in vitro and in vivo.

Authors:  Y Nishiyama; Y Yamada; R Kurachi; T Daikoku
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

2.  Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency.

Authors:  R B Pyles; N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Complementary lethal invasion of the central nervous system by nonneuroinvasive herpes simplex virus types 1 and 2.

Authors:  Y Nishiyama; H Kimura; T Daikoku
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Analysis of viral antigens in giant cells of measles pneumonia by immunoperoxidase method.

Authors:  T Sata; T Kurata; Y Aoyama; M Sakaguchi; K Yamanouchi; K Takeda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 5.  Viruses and the versatile macrophage.

Authors:  P S Morahan; J R Connor; K R Leary
Journal:  Br Med Bull       Date:  1985-01       Impact factor: 4.291

6.  Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.

Authors:  J Chou; E R Kern; R J Whitley; B Roizman
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

7.  A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells.

Authors:  J G Jacobson; D A Leib; D J Goldstein; C L Bogard; P A Schaffer; S K Weller; D M Coen
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

8.  The herpes simplex virus 1 protein kinase encoded by the US3 gene mediates posttranslational modification of the phosphoprotein encoded by the UL34 gene.

Authors:  F C Purves; D Spector; B Roizman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Macrophage extrinsic antiviral activity during herpes simplex virus infection.

Authors:  P S Morahan; S S Morse; M G McGeorge
Journal:  J Gen Virol       Date:  1980-02       Impact factor: 3.891

10.  THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGE.

Authors:  R T JOHNSON
Journal:  J Exp Med       Date:  1964-09-01       Impact factor: 14.307

View more
  16 in total

1.  Role of pseudorabies virus Us3 protein kinase during neuronal infection.

Authors:  L M Olsen; T H Ch'ng; J P Card; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function.

Authors:  Ping Rao; Hong Thanh Pham; Arpita Kulkarni; Yang Yang; Xueqiao Liu; David M Knipe; Peter Cresswell; Weiming Yuan
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

3.  Subcellular localization of the alphaherpesvirus serine/threonine kinase Us3 as a determinant of Us3 function.

Authors:  Renée L Finnen; Bruce W Banfield
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

4.  Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase.

Authors:  P R Kinchington; K Fite; S E Turse
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  A novel oncolytic herpes simplex virus that synergizes with phosphoinositide 3-kinase/Akt pathway inhibitors to target glioblastoma stem cells.

Authors:  Ryuichi Kanai; Hiroaki Wakimoto; Robert L Martuza; Samuel D Rabkin
Journal:  Clin Cancer Res       Date:  2011-04-19       Impact factor: 12.531

6.  Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship.

Authors:  Brent J Ryckman; Richard J Roller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Herpes simplex virus protein kinases US3 and UL13 modulate VP11/12 phosphorylation, virion packaging, and phosphatidylinositol 3-kinase/Akt signaling activity.

Authors:  Heather E Eaton; Holly A Saffran; Frederick W Wu; Kevin Quach; James R Smiley
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

8.  The varicella-zoster virus ORF66 protein induces kinase activity and is dispensable for viral replication.

Authors:  T C Heineman; K Seidel; J I Cohen
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.

Authors:  J F Moffat; L Zerboni; M H Sommer; T C Heineman; J I Cohen; H Kaneshima; A M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

10.  Herpes Simplex Virus 1 Specifically Targets Human CD1d Antigen Presentation To Enhance Its Pathogenicity.

Authors:  Ping Rao; Xiangshu Wen; Jae Ho Lo; Seil Kim; Xin Li; Siyang Chen; Xiaotian Feng; Omid Akbari; Weiming Yuan
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.